Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.

AKTUALNOŚCI >> Mabion s.a. at the central european life science investment conference

Mabion s.a. at the central european life science investment conference

We encourage you to attend the Eighth Central European Life Science Investment Conference. During the meeting, Artur Chabowski, President of the Management Board of Mabion S.A. will present a case study on the development and commercialisation of Poland’s first biosimilar drug: MabionCD20. The meeting will be attended by representatives of the pharmaceutical and biotechnology industry from Poland and abroad, as well as public and private funds investing in this sector.

© Mabion S.A. all rights reserved Polityka Prywatności